DA Davidson Forecasts Clorox’s Q2 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Investment analysts at DA Davidson issued their Q2 2025 earnings per share estimates for Clorox in a research note issued to investors on Monday, November 4th. DA Davidson analyst L. Weiser anticipates that the company will earn $1.27 per share for the quarter. DA Davidson has a “Neutral” rating and a $171.00 price objective on the stock. The consensus estimate for Clorox’s current full-year earnings is $6.81 per share.

Other equities analysts also recently issued research reports about the company. Barclays increased their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. TD Cowen initiated coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective for the company. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, Wells Fargo & Company reduced their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $151.57.

Clorox Stock Performance

Shares of CLX stock opened at $162.37 on Tuesday. The stock has a fifty day moving average of $161.75 and a 200 day moving average of $146.46. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.10 billion, a price-to-earnings ratio of 56.57, a PEG ratio of 3.11 and a beta of 0.41. Clorox has a 52 week low of $125.46 and a 52 week high of $169.09.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm posted $0.49 earnings per share. The firm’s revenue was up 27.0% on a year-over-year basis.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.01%. Clorox’s payout ratio is 170.03%.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.57% of the company’s stock.

Institutional Trading of Clorox

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after purchasing an additional 48,632 shares during the period. Nuance Investments LLC increased its stake in Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after acquiring an additional 960,094 shares during the last quarter. Van ECK Associates Corp increased its stake in Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after acquiring an additional 31,510 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Clorox by 14.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after acquiring an additional 120,716 shares during the last quarter. Finally, Acadian Asset Management LLC increased its stake in Clorox by 26.5% in the 1st quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after acquiring an additional 184,847 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.